InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.03
(
-0.12%
)
Bitcoin
66,567.33
(
-0.11%
)
Post# of 54032
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

loanranger

Send PM Follow Ignore
Followers 209
Posts 32156
Boards Moderated 1
Alias Born 06/30/2009

loanranger

Member Level

Re: None

Monday, 03/15/2021 8:41:29 AM

Monday, March 15, 2021 8:41:29 AM

Post# of 54032
"On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”."

For starters that statement, made MANY times, is false. The Company hadn't filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™ as of March 18th.

Doesn't the truth matter anymore?

Are we going to get to see that document before it expires and along with that it's desired benefit?

https://www.globenewswire.com/news-release/2020/03/18/2002568/0/en/Tauriga-Sciences-Inc-Files-Provisional-U-S-Patent-Application-Covering-its-Pharmaceutical-Grade-Version-of-Tauri-Gum.html


There are none so blind as those who will not see.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up